Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MO vs GSK✓SelectedUSD · GSKMO vs GSK performance historyLatest closeAs of+0.33%11/16
Stock and ETF performance explorer

MO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+150.5%
GSK return
+107.3%
Excess return
+43.2%
Maximum drawdown
-53.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-0.1%+0.4%+0.4%
7D+4.1%-1.3%+5.4%+4.5%
30D+5.0%+2.7%+2.3%+4.1%
3M+22.0%+2.7%+19.3%+20.8%
6M+11.3%+3.3%+8.0%+10.0%
YTD+43.5%+6.5%+37.0%+39.7%
1Y+44.8%+10.7%+34.1%+39.3%
3Y+142.1%+64.4%+77.8%+100.1%
5Y+160.6%+46.7%+113.9%+120.6%
10Y+150.5%+109.4%+41.2%+82.0%
All+150.5%+107.3%+43.2%+82.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling